Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study

Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment With the Zenith® Fenestrated AAA Endovascular Graft and the Zenith® p-Branch® and the Effects on Organ and Extremity Perfusion

The Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Single-Center Study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic aneurysms.

Inclusion Criteria:

• Abdominal aortic aneurysm > 5.0 cm or 2 times the normal aortic diameter
• Abdominal aortic aneurysm with history of growth > 0.5 cm in 6 months
• Penetrating juxtarenal aortic ulcer > 10 mm in depth and 20 mm in diameter

Exclusion Criteria:

• Age < 18 years
• Life expectancy < 2 years
• Pregnant or breast feeding
• Inability or refusal to give informed consent
• Unwilling or unable to comply with the follow-up schedule
• Additional medical restrictions as specified in the Clinical Investigation Plan
• Additional anatomical restrictions as specified in the Clinical Investigation Plan